← Catalyst calendarAKTS biotech catalysts & pipeline
AKTIS ONCOLOGY INC · Data as of 2026-10-25
Upcoming catalysts
[ 225 Ac]Ac-AKY-1189 — Initial data
Q1 2027
We have commenced a multi-site Phase 1b clinical trial in the United States and anticipate preliminary results from the Part-1 dose escalation portion of this trial in the first quarter of 2027.
Source filingAKY-1189 — Initial data
Q1 2027
Expect preliminary data from the ongoing Phase 1b NECTINIUM-2 clinical trial in the first quarter of 2027.
Source filingAKY-2519 — Initial data
2027
Expect preliminary data from Phase 1b mCRPC clinical trial in 2027.
Source filingExplore the free biotech catalyst calendar
